Study to investigate the Safety, Tolerability and Pharmacokinetics of AZD1940
Study identifier:D3120C00003
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Phase I, Multi-Centre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1940, Including an Interaction Study, After Administration of Oral Multiple Ascending Doses in Adult Subjects with Chronic Low Back Pain
Medical condition
low back pain
Phase
Phase 1
Healthy volunteers
No
Study drug
AZD1940, Midazolam
Sex
All
Actual Enrollment
60
Study type
Interventional
Age
20 Years - 65 Years
Date
Study Start Date: 01 Mar 2008
Primary Completion Date: 01 Nov 2008
Study Completion Date: 01 Nov 2008
Study design
Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Experimental: 1 AZD1940 + Placebo | Drug: AZD1940 Oral solution Multiple ascending dose given orally once daily at day 1-12 |
| Other: 2 | Drug: Midazolam Oral solution given orally once daily on day -1 and day 14 |
Contacts
Investigators
Principal Investigator
Janet Post
AstraZeneca R&D SödertäljeSE
